Total Payments
$379,075
2024 Payments
$222.77
Companies
11
Transactions
592
Medicare Patients
237
Medicare Billing
$25,412
Payment Breakdown by Category
Other$304,880 (80.4%)
Consulting$34,435 (9.1%)
Travel$21,606 (5.7%)
Food & Beverage$17,638 (4.7%)
Education$515.89 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $304,130 | 122 | 80.2% |
| Consulting Fee | $34,435 | 9 | 9.1% |
| Travel and Lodging | $21,606 | 65 | 5.7% |
| Food and Beverage | $17,638 | 387 | 4.7% |
| Honoraria | $750.00 | 1 | 0.2% |
| Education | $515.89 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $253,326 | 302 | $0 (2024) |
| Janssen Products, LP | $80,345 | 84 | $0 (2023) |
| Gilead Sciences, Inc. | $34,542 | 87 | $0 (2023) |
| Theratechnologies Inc. | $7,387 | 16 | $0 (2023) |
| Janssen Biotech, Inc. | $2,076 | 84 | $0 (2023) |
| GlaxoSmithKline, LLC. | $880.26 | 9 | $0 (2019) |
| EMD Serono, Inc. | $200.39 | 3 | $0 (2021) |
| AbbVie, Inc. | $184.24 | 2 | $0 (2018) |
| MannKind Corporation | $62.20 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $54.00 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.77 | 2 | ViiV Healthcare Company ($222.77) |
| 2023 | $45,560 | 31 | ViiV Healthcare Company ($39,847) |
| 2022 | $53,241 | 78 | ViiV Healthcare Company ($33,468) |
| 2021 | $59,318 | 87 | ViiV Healthcare Company ($52,929) |
| 2020 | $52,248 | 78 | ViiV Healthcare Company ($45,329) |
| 2019 | $92,017 | 143 | ViiV Healthcare Company ($66,735) |
| 2018 | $35,461 | 78 | Janssen Products, LP ($15,911) |
| 2017 | $41,007 | 95 | Janssen Products, LP ($18,978) |
All Payment Transactions
592 individual payment records from CMS Open Payments — Page 2 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/17/2023 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: HIV | ||||||
| 03/17/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $117.55 | General |
| Category: HIV | ||||||
| 03/15/2023 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 03/15/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: HIV | ||||||
| 03/10/2023 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 02/15/2023 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: HIV | ||||||
| 01/25/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $37.70 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 01/13/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: HIV | ||||||
| 12/23/2022 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/16/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: HIV | ||||||
| 12/14/2022 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/14/2022 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/14/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.71 | General |
| 12/08/2022 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $65.22 | General |
| Category: HIV | ||||||
| 12/07/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $34.38 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 12/06/2022 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $13.79 | General |
| 12/05/2022 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $117.42 | General |
| 12/01/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HIV | ||||||
| 11/16/2022 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/04/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $57.44 | General |
| Category: HIV | ||||||
| 11/03/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: HIV | ||||||
| 10/28/2022 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: HIV | ||||||
| 10/28/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $39.45 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 10/28/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.50 | General |
| 10/25/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 31 | 66 | $12,770 | $3,195 |
| 2022 | 2 | 51 | 98 | $23,741 | $7,310 |
| 2021 | 2 | 53 | 97 | $23,476 | $7,757 |
| 2020 | 5 | 102 | 134 | $26,081 | $7,150 |
Total Patients
237
Total Services
395
Medicare Billing
$25,412
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 31 | 66 | $12,770 | $3,195 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 37 | 84 | $16,735 | $4,475 | 26.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2022 | 14 | 14 | $7,006 | $2,834 | 40.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 32 | 76 | $15,219 | $4,393 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 21 | 21 | $8,257 | $3,364 | 40.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 43 | 69 | $10,502 | $2,454 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 14 | 14 | $4,799 | $1,938 | 40.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 13 | 16 | $4,400 | $1,214 | 27.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 20 | 21 | $3,150 | $943.06 | 29.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 12 | 14 | $3,230 | $601.12 | 18.6% |
About Andre Brutus
Andre Brutus is a Infectious Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760425458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andre Brutus has received a total of $379,075 in payments from pharmaceutical and medical device companies, with $222.77 received in 2024. These payments were reported across 592 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($304,130).
As a Medicare-enrolled provider, Brutus has provided services to 237 Medicare beneficiaries, totaling 395 services with total Medicare billing of $25,412. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Brooklyn, NY
- Active Since 06/13/2006
- Last Updated 09/12/2013
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1760425458
Products in Payments
- DOVATO (Drug) $198,779
- SYMTUZA (Drug) $32,230
- Symtuza (Drug) $20,477
- PREZCOBIX (Drug) $14,386
- TIVICAY (Drug) $12,381
- Biktarvy (Drug) $6,403
- Genvoya (Drug) $5,528
- EGRIFTA (Drug) $3,065
- JULUCA (Drug) $1,603
- TROGARZO (Drug) $1,543
- TRIUMEQ (Drug) $376.93
- APRETUDE (Biological) $262.62
- Viekira (Drug) $148.31
- Truvada (Drug) $123.32
- AFREZZA (Drug) $62.20
- Mavyret (Drug) $35.93
- SEROSTIM (Biological) $19.02
- DARAPRIM (Drug) $18.08
- CABENUVA (Biological) $17.38
- ZEPATIER (Drug) $16.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Brooklyn
Dr. Joseph Paul, M.d, M.D
Infectious Disease — Payments: $294,392
Infectious Disease $294,392
Marcus Sandling
Infectious Disease — Payments: $69,398
Infectious Disease $69,398
Dr. Jessica Yager, M.d, M.D
Infectious Disease — Payments: $46,298
Infectious Disease $46,298
Yusuf Afacan, M.d, M.D
Infectious Disease — Payments: $27,239
Infectious Disease $27,239
Dr. Jacquelyn Lahoud, M.d, M.D
Infectious Disease — Payments: $9,095
Infectious Disease $9,095
Olga Badem, Md, MD
Infectious Disease — Payments: $6,500
Infectious Disease $6,500